Noble Capital Markets ’ J.P. Morgan Healthcare Conference Takeaways hosted by ChannelChek featuring an interview with Noble Capital Market’s managing director and senior biotechnology analystRobert LeBoyer discussing management’s perspective on the market environment for biotechnology companies and Cocrystal’s opportunity. The Takeaways event is available beginning today,January 26 , at11:00 a.m. Eastern time . Register here for the event.Noble Capital Markets C-Suite Interview Series hosted by ChannelChek featuring an interview withMr. LeBoyer with an update on Cocrystal’s influenza and COVID-19 antiviral programs and upcoming clinical and regulatory milestones. The interview will be available byFebruary 1 on the ChannelChek platform by registering here.- Sequire’s
Virtual Biotechnology Conference featuring a company presentation onThursday, February 2 at11:30 a.m. Eastern time Eastern time. Register here for the presentation.
About ChannelChek
Channelchek.com is a comprehensive investor-centric portal featuring more than 6,000 emerging growth companies that provides advanced market data, independent research, balanced news, video webcasts, exclusive c-suite interviews, and access to virtual road shows. The site is available to the public. Research on Channelchek is provided by
About Sequire
Sequire is a premier investor intelligence and communications platform where companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. More information is available at srax.com and mysequire.com.
About
Investor Contact:
LHA Investor Relations
310-691-7100
jcain@lhai.com
Media Contact:
917-885-7378
Jabraham@jqapartners.com
# # #
![](https://ml.globenewswire.com/media/OGZmZTliYzktOTgxYi00N2E0LWJlY2UtZWMxYTA4NWZiYjc1LTEwOTU4NDk=/tiny/Cocrystal-Pharma-Inc-.png)
2023 GlobeNewswire, Inc., source